Olga Kantor, MD, MS, Monica L. Wang, ScD, MS, Kimberly Bertrand, MPH, ScD, Lori Pierce, MD, Rachel A. Freedman, MD, MPH, Mariana Chavez-MacGregor, MD, Tari A. King, MD, and Elizabeth… Click to show full abstract
Olga Kantor, MD, MS, Monica L. Wang, ScD, MS, Kimberly Bertrand, MPH, ScD, Lori Pierce, MD, Rachel A. Freedman, MD, MPH, Mariana Chavez-MacGregor, MD, Tari A. King, MD, and Elizabeth A. Mittendorf, MD, PhD Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA; Breast Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA; Harvard Medical School, Boston, MA; Community Health Sciences, Boston University School of Public Health, Boston, MA; Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA; Slone Epidemiology Center at, Boston University, Boston, MA; Boston University School of Medicine, Boston, MA; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX
               
Click one of the above tabs to view related content.